Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease.
Blann
A D
AD
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom. a.blann@bham.ac.uk
Gurney
D
D
Hughes
E
E
Buggins
P
P
Silverman
S H
SH
Lip
G Y
GY
D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000032:analysis / Q000187:drug effects; D016022:Case-Control Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood / Q000187:drug effects; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D019007:P-Selectin / Q000097:blood / Q000187:drug effects; D016491:Peripheral Vascular Diseases / Q000150:complications*; D017035:Pravastatin / Q000627:therapeutic use*; D018709:Statistics, Nonparametric; D014841:von Willebrand Factor / Q000032:analysis / Q000187:drug effects
D000924:Anticholesteremic Agents; D008055:Lipids; D019007:P-Selectin; D014841:von Willebrand Factor; D018799:Intercellular Adhesion Molecule-1; D002097:C-Reactive Protein; D017035:Pravastatin